Global immunohematology market to reach $4.1b by 2034

Key trends include next-gen blood processing systems.

The global immunohematology market is projected to reach $4.1b by 2034 at a compound annual growth rate (CAGR) of 4.83% from 2029, according to Research and Markets.

Projections indicate the market will grow to $3.17b by 2029, reflecting a CAGR of 5.24% from 2024.

The sector’s expansion is attributed to the rising prevalence of blood disorders and infectious diseases, increasing healthcare expenditure, a rise in trauma and accident cases, and favourable government funding.

Current market trends include the development of next-generation blood processing systems with advanced automation, along with the use of multiplex analysis to improve blood transfusion management.

Key strategies amongst industry players include forming strategic partnerships to improve business capabilities and launching new products to strengthen operations.